Institutes outside Greece
Untersuchung über die gefäßsteifigkeit mittels pulswellengeschwindigkeit bei patienten mit rheumatischen erkrankungen im rheumazentrum Rheinland-Pfalz
Abstract
dc:descriptionSystemic-inflammatory rheumatic diseases correlate with increased cardiovascular (CV) risk and higher morbidity and mortality rates (1). During the last years, a close associationbetween the occurence of CV events and an increase of aortic stiffness has been shown in multiple studies. Aortic stiffness has been hence described as an independent predictor of CV risk (2). An increase of aortic stiffness has also been observed in various systemic-inflammatory rheumatic diseases (3-5). Pathophysiological reasons for this seem to be inflammation associated effects, such as endothelial dysfunction, acceleration of atherosclerosis, pathologic functions of lipoporoteins, presence of various autoantibodies, abnormal vasospasm and a disruption of the normal process of elastin production/degradation within the artery wall. Peripheral and central arterial stiffness can nowadays be measured by several methods. Among these methods, carotid-femoral pulse wave velocity (cfPWV) has the most epidemiological evidence regarding a high predictive value of CV events and this modality is described in the scientific literature as the ‘‘gold standard‘‘ assessment method of aortic stiffness (6). Moreover, cfPWV is a simple, complication-free and inexpensive method for theearly detection of patients under high CV risk (7). In the present work, aortic stiffness of patients with three different systemic-inflammatory rheumatic diseases [systemic sclerosis (SSc), systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA)] has been examined by cfPWV. Moreover, correlations of cfPWV with various patient- and disease associated-parameters, such as inflammation markers, disease specific autoantibodies, secondary organ involvement and traditional CV risk factors, such as diabetes, nicotine use, arterial hypertension and lipid profile have been evaluated. Hereby, it could be shown that patients with SSc and RA had significantly higher cfPWV values in comparison to healthy controls (p<0.001 and p=0.026, respectively). In the SLE subgroup, no statistically significant differences of cfPWV between patients and control subjects was found (p>0.05). A possible reason for that could be the clinical heterogeneity characterising the entity of SLE.In a second step, correlations of aortic stiffness with traditional CV risk factors and disease-associated characteristics were examined. In accordance with the scientific literature, a statistically significant association between cfPWV and age could be shown in both the SSc- and RA-subgroup (p=0.004 and p=0.033, respectively). Moreover, in patients with SSc, cfPWV correlated significantly with arterial hypertension and presence of type II diabetes mellitus. In the same subgroup, patients with arthritis and/or acroosteolyses showed additionally statistically significant lower cfPWV values in comparison to their counterparts without a joint involvement. Nevertheless, statistical control via multivariable linear regression analyses showed that solely diabetes (padj<0.001) and age (padj=0.002) had a significant association with cfPWV in the cohort. No other significant correlations between cfPWV and various SSc-clinical, -laboratory and -medication associated parameters could be found. In the RA subgroup, a statistically significant association between cfPWV and rheumatoid factor (RF) was established (8). However, the relationship did not remain significant after statistically adjusting the results for the effect of age (padj>0.05). A possible reason could be the known positive association between RF and age (older subjects have often higher titers of RF). Interestingly enough, a marginal correlation between cfPWV and the count of tender, rather the count of swollen, joints was found (p=0.055) (8). This could be an indication of a separate, inflammation - independent effect of pain on aortic stiffness/stiffening. Given the fact that at the time of the doctoral thesis no adequate data on this relationship existed, it was suggested that this result should be further examined (8). This examination was indeed performed subsequently by our group in another study which included patients with the known rheumatic chronic pain syndrome fibromyalgia (FM) (9). Here, we showed that included patients with FM had higher cfPWV compared with controls (9).In the SLE-subgroup, no statistically significant correlations between cfPWV and markers of activity or chronicity of the disease were established. The value of this examination in the follow-up assessments of patients with either increased cfPWV-values or past CV-eventsremains however high. In summary, the present work constituted a further step in the validation of an increased aortic stiffness in patients with some of the rheumatic diseases included. Given the fact that cfPWV is a well validated marker of CV risk, these results are of significance. Furthermore, it couldbe shown that traditional CV risk factors, rather than the examined disease associated parameters, were associated with an increased aortic stiffness and thus should be taken into account when treating patients with systemic-inflammatory rheumatic diseases. The measurement of cfPWV seems to be a valuable tool to assist identificantion of rheumatic patients under increased CV risk and thus allow early treatment initiation and ultimately prognosis improvement. Further prospective studies examining the influence of pain and / or immunosuppressive therapy on the vasculature of patients with inflammatory-rheumatic systemic diseases are needed.
Degree
thesis:*- Grantor dc:publisher
- Institutes outside Greece
- Year dc:date
- 2015
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Triantafyllias, Konstantinos
- Τριανταφυλλιάς, Κωνσταντίνος
Subjects
dc:subject × 16- Αορτική ταχύτητα παλμικού κύματος
- Αορτική σκληρότητα
- Ρευματοειδής αρθρίτιδα
- Συστηματική σκληροδερμία
- Συστηματικός ερυθηματώδης λύκος ( ΣΕΛ)
- Aortic pulse wave velocity
- Aortic stiffness
- Rheumatoid arthritis
- Systematic scleroderma
- Systemic lupus erythematosus (SLE)
- Κλινική Ιατρική
- Ιατρική και Επιστήμες Υγείας
- Ρευματολογία
- Clinical Medicine
- Medical and Health Sciences
- Rheumatology
Rights
- Language dc:language
- ger
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/54368